Martin Carlsson

MD, PhD, specialised in Endocrinology, Diabetology, Internal medicine and Clinical Chemistry

Martin Carlsson is a physician, Associate Professor and specialist in endocrinology. He is co-founder and Chief Medical Officer at Yazen Health, with a research background in type 2 diabetes, overweight, obesity and the digitalisation of healthcare.

Orange stylized human head with colorful flowers and vines growing out from the top and back.

Martin Carlsson is a physician and specialist in endocrinology/diabetology, internal medicine and clinical chemistry.

He studied medicine at Karolinska Institutet, followed by doctoral research at Lund University on type 2 diabetes and the genetics of overweight and obesity.

Today, he is an Associate Professor at Linnaeus University, with main research interests in hypertension, type 2 diabetes, overweight and obesity, vitamin D, the metabolic syndrome and the digital transformation of healthcare.

Martin has authored more than 40 peer-reviewed scientific papers and contributed to several medical textbooks. He is the founder of the e-health company Accumbo AB (now Blodtrycksdoktorn) and co-founder and Chief Medical Officer of Yazen Health, where he is dedicated to developing the future of care for people living with overweight and obesity.

Articles by

Martin Carlsson

Medicine

What to think about when travelling with refrigerated weight loss medication (Wegovy, Ozempic, Mounjaro, Saxenda etc)

Health and lifestyle

Understanding weight gain: The role of genetics, lifestyle, and internal thermostat

Science and publications

New research: over a third of Brits see obesity as a personal choice

A new survey by Yazen Health uncovers widespread misconceptions about obesity, with over one-third of Brits seeing it as a personal choice rather than a chronic disease. These findings highlight the urgent need for greater public education and medically-guided obesity care.

Science and publications

The Yazen model: Obesity care through a comprehensive digital approach integrating medical treatment, lifestyle intervention, and social support

Science and publications

Examining the effectiveness of a new digital care model on weight loss for people living with obesity

Medicine

The Synergy between Ozempic, Wegovy, & a Healthy Lifestyle

Medicine

The Rise of Ozempic, Wegovy, Mounjaro and new pills for weight loss

© 2025 Yazen. All rights reserved.

Yazen Health AB operates as a registered healthcare provider under the General Data Protection Regulation (GDPR), the Swedish Health and Medical Care Act, Patient Data Act, and the Patient Security Act. Our proprietary systems, including the patient app and electronic medical record (EMR) system, are officially registered with the Swedish Health and Social Care Inspectorate (IVO).

Featured news & articles

Featured news & articles

Martin Carlsson

Articles by

Martin Carlsson

What to think about when travelling with refrigerated weight loss medication (Wegovy, Ozempic, Mounjaro, Saxenda etc)

Understanding weight gain: The role of genetics, lifestyle, and internal thermostat

New research: over a third of Brits see obesity as a personal choice

The Yazen model: Obesity care through a comprehensive digital approach integrating medical treatment, lifestyle intervention, and social support

Examining the effectiveness of a new digital care model on weight loss for people living with obesity

The Synergy between Ozempic, Wegovy, & a Healthy Lifestyle

The Rise of Ozempic, Wegovy, Mounjaro and new pills for weight loss